Patrick Donnelly
Stock Analyst at Citigroup
(5.00)
# 11
Out of 4,896 analysts
332
Total ratings
52.25%
Success rate
153.86%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Upgrades: Buy | $150 → $200 | $159.40 | +25.47% | 21 | Jul 9, 2025 | |
| HOLX Hologic | Upgrades: Buy | $60 → $80 | $65.72 | +21.73% | 15 | Jul 9, 2025 | |
| ILMN Illumina | Downgrades: Sell | $85 → $80 | $99.25 | -19.40% | 17 | Jul 9, 2025 | |
| BRKR Bruker | Downgrades: Neutral | $50 → $40 | $43.79 | -8.65% | 16 | May 22, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $256.97 | +36.20% | 15 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $257.75 | +35.79% | 15 | May 2, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $290 → $215 | $150.52 | +42.84% | 9 | Apr 7, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,400 | $1,223.93 | +14.39% | 13 | Apr 7, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $20 → $15 | $12.80 | +17.19% | 12 | Mar 4, 2025 | |
| AVTR Avantor | Maintains: Neutral | $22 → $18 | $13.58 | +32.55% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $54.14 | +29.29% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $210 | $162.80 | +28.99% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $650 → $570 | $434.86 | +31.08% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $168.09 | +10.06% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $204.85 | +29.36% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $5.11 | +350.10% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $44 → $50 | $30.34 | +64.80% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $11.80 | +69.49% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $51.91 | +44.48% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $123.28 | +33.84% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $50.25 | -10.45% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $25.21 | +11.07% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $101.50 | +42.86% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $48.13 | +28.40% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $352.91 | -14.99% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.10 | +190.32% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $2.84 | -3.17% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $249.62 | +4.16% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $6.37 | -5.81% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $5.35 | +498.69% | 2 | Nov 30, 2018 |
Charles River Laboratories International
Jul 9, 2025
Upgrades: Buy
Price Target: $150 → $200
Current: $159.40
Upside: +25.47%
Hologic
Jul 9, 2025
Upgrades: Buy
Price Target: $60 → $80
Current: $65.72
Upside: +21.73%
Illumina
Jul 9, 2025
Downgrades: Sell
Price Target: $85 → $80
Current: $99.25
Upside: -19.40%
Bruker
May 22, 2025
Downgrades: Neutral
Price Target: $50 → $40
Current: $43.79
Upside: -8.65%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $256.97
Upside: +36.20%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $257.75
Upside: +35.79%
ICON Public Limited Company
Apr 7, 2025
Maintains: Buy
Price Target: $290 → $215
Current: $150.52
Upside: +42.84%
Mettler-Toledo International
Apr 7, 2025
Upgrades: Buy
Price Target: $1,400
Current: $1,223.93
Upside: +14.39%
10x Genomics
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $12.80
Upside: +17.19%
Avantor
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $13.58
Upside: +32.55%
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $54.14
Upside: +29.29%
Mar 4, 2025
Maintains: Neutral
Price Target: $225 → $210
Current: $162.80
Upside: +28.99%
Mar 4, 2025
Maintains: Neutral
Price Target: $650 → $570
Current: $434.86
Upside: +31.08%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $168.09
Upside: +10.06%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $204.85
Upside: +29.36%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $5.11
Upside: +350.10%
Dec 11, 2024
Upgrades: Buy
Price Target: $44 → $50
Current: $30.34
Upside: +64.80%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $11.80
Upside: +69.49%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $51.91
Upside: +44.48%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $123.28
Upside: +33.84%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $50.25
Upside: -10.45%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $25.21
Upside: +11.07%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $101.50
Upside: +42.86%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $48.13
Upside: +28.40%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $352.91
Upside: -14.99%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $3.10
Upside: +190.32%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $2.84
Upside: -3.17%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $249.62
Upside: +4.16%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $6.37
Upside: -5.81%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $5.35
Upside: +498.69%